Here are the UK's top-paid FTSE 100 CEOs — as report finds exec salaries at record high

FTSE 100 CEO median pay surged to a record £4.58 million in the latest financial year, up from £4.29 million and marking the highest figure since 2013, according to the High Pay Centre. This compensation, which includes a mean bonus of £1.61 million, is 122 times the average UK worker's salary, highlighting persistent concerns over executive remuneration and wealth distribution. The report also noted a significant gender pay gap, with female CEOs earning considerably less than their male counterparts and no women among the top 10 highest-paid executives, raising further questions about corporate governance and diversity within the UK's largest listed firms.

Analysis

Median pay for FTSE 100 CEOs reached a record £4.58 million in the latest financial year, an increase from £4.29 million previously and the highest level since single-figure disclosure was mandated in 2013. This trend, which includes a rise in mean bonus payments to £1.61 million, highlights escalating executive remuneration structures. The data reveals significant governance and social considerations, most notably a CEO-to-average-worker pay ratio of 122:1 and a material gender pay disparity, with the median pay for female CEOs at £3.27 million compared to £4.64 million for their male counterparts. The absence of any women in the top 10 highest-paid executives further underscores this gap. While the immediate market impact of this report is low, the negative sentiment associated with firms like Pearson and AstraZeneca, which feature high on the pay list, points to a persistent reputational and ESG risk factor. This information is a direct result of post-2019 disclosure regulations, indicating that corporate pay practices will remain under intense public and regulatory scrutiny.

Key Decisions for Investors

• Investors with ESG mandates should scrutinize the compensation practices and board diversity of FTSE 100 companies, using this report's data to assess the 'Social' and 'Governance' pillars of their holdings.
• The ongoing regulatory focus on executive pay signals a potential for future legislative action or increased shareholder activism, representing a long-term risk factor that warrants monitoring.
• For specific holdings in companies named with high executive pay, such as Pearson or AstraZeneca, it is prudent to review remuneration committee reports to ensure compensation is strongly linked to long-term performance and shareholder value creation, thereby mitigating reputational risk.